» Articles » PMID: 36462503

Functional Proteomic Profiling Links Deficient DNA Clearance with Increased Mortality in Individuals with Severe COVID-19 Pneumonia

Abstract

The factors that influence survival during severe infection are unclear. Extracellular chromatin drives pathology, but the mechanisms enabling its accumulation remain elusive. Here, we show that in murine sepsis models, splenocyte death interferes with chromatin clearance through the release of the DNase I inhibitor actin. Actin-mediated inhibition was compensated by upregulation of DNase I or the actin scavenger gelsolin. Splenocyte death and neutrophil extracellular trap (NET) clearance deficiencies were prevalent in individuals with severe COVID-19 pneumonia or microbial sepsis. Activity tracing by plasma proteomic profiling uncovered an association between low NET clearance and increased COVID-19 pathology and mortality. Low NET clearance activity with comparable proteome associations was prevalent in healthy donors with low-grade inflammation, implicating defective chromatin clearance in the development of cardiovascular disease and linking COVID-19 susceptibility to pre-existing conditions. Hence, the combination of aberrant chromatin release with defects in protective clearance mechanisms lead to poor survival outcomes.

Citing Articles

Neutrophils restricted contribution of genetic variants to COVID-19 severity.

Laffranchi M, Paraboschi E, Bianchetto-Aguilera F, Tamassia N, Gasperini S, Gardiman E Heliyon. 2025; 11(1):e41267.

PMID: 39811276 PMC: 11731188. DOI: 10.1016/j.heliyon.2024.e41267.


Exercise intensity and training alter the innate immune cell type and chromosomal origins of circulating cell-free DNA in humans.

Rodrigues K, Weng Z, Graham Z, Lavin K, McAdam J, Tuggle S Proc Natl Acad Sci U S A. 2025; 122(3):e2406954122.

PMID: 39805013 PMC: 11761974. DOI: 10.1073/pnas.2406954122.


A cyclic peptide toolkit reveals mechanistic principles of peptidylarginine deiminase IV regulation.

Bertran M, Walmsley R, Cummings T, Aramburu I, Benton D, Mora Molina R Nat Commun. 2024; 15(1):9746.

PMID: 39528459 PMC: 11555231. DOI: 10.1038/s41467-024-53554-1.


Development of a Clonal and High-Yield Mammalian Cell Line for the Manufacturing of a Hyperactive Human DNase I with Extended Plasma Half-Life Using PASylation Technology.

Stamm S, Wagner R, Lang D, Skerra A, Gebauer M Pharmaceutics. 2024; 16(7).

PMID: 39065664 PMC: 11280007. DOI: 10.3390/pharmaceutics16070967.


Anti-inflammatory therapy with nebulized dornase alfa for severe COVID-19 pneumonia: a randomized unblinded trial.

Porter J, Inshaw J, Solis V, Denneny E, Evans R, Temkin M Elife. 2024; 12.

PMID: 39009040 PMC: 11251720. DOI: 10.7554/eLife.87030.


References
1.
Raju M S, V J, Kamaraju R, Sritharan V, Rajkumar K, Natarajan S . Continuous evaluation of changes in the serum proteome from early to late stages of sepsis caused by Klebsiella pneumoniae. Mol Med Rep. 2016; 13(6):4835-44. DOI: 10.3892/mmr.2016.5112. View

2.
Dinsdale R, Hazeldine J, Al Tarrah K, Hampson P, Devi A, Ermogenous C . Dysregulation of the actin scavenging system and inhibition of DNase activity following severe thermal injury. Br J Surg. 2019; 107(4):391-401. PMC: 7079039. DOI: 10.1002/bjs.11310. View

3.
Lee P, Waxman A, Cotich K, Chung S, Perrella M, Stossel T . Plasma gelsolin is a marker and therapeutic agent in animal sepsis. Crit Care Med. 2007; 35(3):849-55. DOI: 10.1097/01.CCM.0000253815.26311.24. View

4.
Lazarides E, Lindberg U . Actin is the naturally occurring inhibitor of deoxyribonuclease I. Proc Natl Acad Sci U S A. 1974; 71(12):4742-6. PMC: 433972. DOI: 10.1073/pnas.71.12.4742. View

5.
Dittmar M, Poppe R, Bischofs C, Fredenhagen G, Kanitz M, Kahaly G . Impaired deoxyribonuclease activity in monoglandular and polyglandular autoimmunity. Exp Clin Endocrinol Diabetes. 2007; 115(6):387-91. DOI: 10.1055/s-2007-967082. View